Biotech News
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
investors.milestonepharma.com2026-05-06 15:26 EST
New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and